Farther Finance Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.5K Buy
3,245
+323
+11% +$4.4K ﹤0.01% 3527
2026
Q2
$39.6K Sell
2,922
-217
-7% -$2.6K ﹤0.01% 3438
2026
Q1
$19.3K Sell
3,139
-1,210
-28% -$9.11K ﹤0.01% 3690
2025
Q4
$31.2K Buy
4,349
+2,033
+88% +$16.1K ﹤0.01% 3129
2025
Q3
$24.7K Buy
2,316
+988
+74% +$9.7K ﹤0.01% 2892
2025
Q2
$12.9K Sell
1,328
-1,053
-44% -$10.9K ﹤0.01% 2938
2025
Q1
$33.6K Buy
2,381
+627
+36% +$9.64K ﹤0.01% 2107
2024
Q4
$26.2K Buy
1,754
+319
+22% +$5.2K ﹤0.01% 1968
2024
Q3
$27.5K Buy
1,435
+368
+34% +$7.63K ﹤0.01% 1943
2024
Q2
$21.7K Buy
1,067
+502
+89% +$9.98K ﹤0.01% 1754
2024
Q1
$10.4K Buy
565
+64
+13% +$1.1K ﹤0.01% 1749
2023
Q4
$7.23K Buy
501
+145
+41% +$1.97K ﹤0.01% 1777
2023
Q3
$6.19K Sell
356
-38
-10% -$792 ﹤0.01% 1451
2023
Q2
$8.2K Buy
394
+58
+17% +$1.26K ﹤0.01% 1259
2023
Q1
$7.91K Buy
336
+2
+0.6% +$54 ﹤0.01% 1194
2022
Q4
$9.32K Buy
+334
New +$8.54K ﹤0.01% 971

Other funds holding OGN

Farther Finance Advisors's OGN Position: Q3 2026 in Review

Farther Finance Advisors increased its Organon & Co (OGN) stake by 11% in Q3 2026, buying an estimated $4.4K and bringing the position to 3,245 shares worth $44.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3527.

Farther Finance Advisors first reported a position in OGN in Q4 2022 and has held it in 16 quarters since. 33 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Farther Finance Advisors held 3,245 shares of Organon & Co worth $44.5K as of Q3 2026.
  • Farther Finance Advisors bought 323 Organon & Co shares in Q3 2026, an estimated $4.4K.
  • Organon & Co made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3527 holding.
  • Farther Finance Advisors first reported a position in Organon & Co in Q4 2022 and has held it in 16 quarters since.
  • 33 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.